Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading update

24 Nov 2014 07:00

RNS Number : 7387X
Elektron Technology PLC
24 November 2014
 



24 November 2014

 

Elektron Technology plc

 

Third quarter trading update

 

Elektron Technology plc (AIM: EKT, "Elektron" or the "Group"), the global technology group, provides an update on recent trading.

 

The Group is continuing to perform in line with the Board's expectations. Group sales for the third quarter from continuing operations amounted to £11.5m (2013: £11.8m) taking year to date sales to £33.6m (2013: £34.4m) with sales demand tracking the trend of the first half of the year. As expected the Group has seen some weakening in demand from its EMEA Connectivity distributor base due to difficult economic conditions and high stock levels. Conversely Instrumentation Monitoring and Control ("IMC") demand strengthened during the third quarter. The overdue sales backlog at 31 October had been lowered to £0.7 million (31 July 2014: £1.0 million; 31 January 2014: £2.1 million). There were no operating or financing related exceptional charges in the third quarter.

 

Net debt at 31 October was £2.7 million (31 July 2014: £4.7 million; 31 January 2014: £8.0 million).

 

The Group has begun to accelerate investment in key new product development programmes, in particular relating to its Checkit brand, with a number of strategic technical appointments complemented by outsourced development. Consequently the Group expects debt to rise in the final quarter but still be substantially below the half year position.

 

The Group continues to focus on maximising the performance of its existing portfolio of brands in the short term whilst developing and launching innovative new products to enable growth in the medium and longer term.

 

As announced at the half year results in September, the Board remains of the view that the Group's trading performance in the second half of the year will be similar to the first half.

 

John Wilson, Chief Executive Officer of Elektron said:

 

"The Group's delivery of a satisfactory performance in the third quarter is confirmation that our strategy remains on track. The Group is cash generative and we are placing considerable focus on using the funds raised earlier in the year to invest and execute our longer term strategy of building a high growth portfolio of brands through the introduction of best-in-class innovative products to the market." 

 

Enquiries:

 

Elektron Technology www.elektron-technology.com

+44 (0) 1223 371 000

John Wilson - Chief Executive Officer

Andy Weatherstone - Chief Financial Officer

finnCap (Nominated Adviser, Financial Adviser and Broker)

+44 (0)20 7220 0500

Ed Frisby/Scott Mathieson (Corporate Finance)

Malar Velaigam (Corporate Broking)

Instinctif Partners

+44 (0)20 7457 2020

Adrian Duffield/Kay Larsen

 

 

Notes to Editors 

Elektron conceives designs and markets innovative engineered products and services for businesses at its technology hub in Cambridge. It has a multi skilled team of engineers and product line specialists focused on the opportunities created by disruptive global trends in the following areas: 

 

· Demand for ubiquitous power and data: Connectivity Solutions

· Growth in high precision manufacture: Nano-positioning

· Healthcare for the ageing population: Ophthalmology

· Connected customer experiences and service delivery: E-Commerce and E-Service

 

In addition it owns a portfolio of well-established products and brands which provide customer access and feedback. 

 

Elektron Technology is headquartered in Cambridge and its shares are admitted to trading on the AIM market of the London Stock Exchange. 

 

Forward looking statements 

Statements contained in this statement are based on the knowledge and information available to the Company's directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated. To the extent that this Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward looking statements.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFELFMFFLSEDF
Date   Source Headline
7th Jun 20217:00 amRNSAppointment of Non-Executive Director
3rd Jun 202112:25 pmRNSResult of AGM
13th May 20217:00 amRNSTrading Update
10th May 202112:23 pmRNSPosting of Annual Report and Notice of AGM
4th May 20214:02 pmRNSDirector Dealing
29th Apr 202110:00 amRNSBoard Changes
29th Apr 20217:00 amRNSPreliminary Results
21st Apr 20217:00 amRNSProduct update announcement
23rd Mar 20213:54 pmRNSHolding(s) in Company
22nd Mar 202112:33 pmRNSHolding(s) in Company
19th Mar 20217:00 amRNSElectronic Communications
22nd Feb 20217:00 amRNSDirector/PDMR Shareholding
18th Feb 20217:00 amRNSGrant of options and PDMR dealings
11th Feb 20217:00 amRNSTrading Update
4th Feb 20217:00 amRNSAcquisition and Business Development Appointments
21st Dec 20205:14 pmRNSHolding(s) in Company
14th Dec 20207:00 amRNSDirector Dealing, Exercise of Options and TVR
2nd Dec 20207:00 amEQSCheckit (CKT): Initiation - Smarter operations management
2nd Dec 20207:00 amRNSEdison Investment Research Initiates Coverage
1st Dec 20202:30 pmEQSCheckit (CKT): Initiation - Smarter operations management
10th Nov 20207:00 amRNSTrading Update
19th Oct 20207:00 amRNSContract with John Lewis
24th Sep 20207:00 amRNSBoard Changes
21st Sep 20204:27 pmRNSPDMR Dealing
16th Sep 20207:00 amRNSHalf Year Results
12th Aug 20207:00 amRNSTrading update and notice of interim results
6th Aug 20207:00 amRNSBoard Changes
31st Jul 20201:54 pmRNSResult of AGM
9th Jul 20203:38 pmRNSPDMR Dealing
7th Jul 202010:34 amRNSGrant of share options and PDMR dealings
7th Jul 20207:38 amRNSPosting of Annual Report and Notice of AGM
6th Jul 20207:00 amRNSAppointment of CFO designate
1st Jul 202012:40 pmRNSDisposal of assets
16th Jun 20207:00 amRNSPreliminary Results
2nd Jun 20204:15 pmRNSChange to AGM date and arrangements
26th May 20207:00 amRNSCOVID-19 Update and Change to Results Date
5th May 20205:03 pmRNSResignation of Director
21st Apr 20203:20 pmRNSDirector/PDMR Shareholding
14th Apr 20207:00 amRNSCOVID-19 Update
23rd Mar 20206:11 pmRNSDirector/PDMR Shareholding
18th Mar 20205:15 pmRNSDirector/PDMR Shareholding
21st Feb 20204:41 pmRNSSecond Price Monitoring Extn
21st Feb 20204:35 pmRNSPrice Monitoring Extension
21st Feb 20207:00 amRNSDirector/PDMR Shareholding
14th Feb 20207:00 amRNSPDMR Dealing and Concert Party Holdings
13th Feb 20207:00 amRNSTrading Update
3rd Feb 20207:00 amRNSAppointment of Non-Executive Director
23rd Dec 20195:05 pmRNSHolding(s) in Company
18th Dec 20196:25 pmRNSPDMR Dealings
16th Dec 201911:40 amRNSResignation of Director

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.